Poor
solubility, low cellular uptake, and poor cell selectivity
are the main obstacles hampering the therapeutic potential and clinic
application of macromolecules. To overcome these limitations, here
we propose a chemical modification strategy of macromolecules based
on enzyme-instructed self-assembly (EISA). By using protoporphyrin
IX (PpIX) and its metal complex Zn-PpIX as the modification objects,
we demonstrated that the integration of enzymatic transformation and
molecular self-assembly of macromolecules successfully improved the
solubility of macromolecules, enhancing their intracellular uptake
selectively against cancer cells. The proposed strategy is potentially
applicable as a general tool for the development of macromolecule-based
nanomedicine.